Rchr
J-GLOBAL ID:201401046302904233
Update date: Oct. 22, 2021
Takita Masahiro
タキタ マサヒロ | Takita Masahiro
Contact this researcher
You can send email directly to the researcher.
Papers (19):
Tatsuo Inoue, Masatoshi Kudo, Kinuyo Hatanaka, Tadaaki Arizumi, Masahiro Takita, Satoshi Kitai, Norihisa Yada, Satoru Hagiwara, Yasunori Minami, Toshiharu Sakurai, et al. Usefulness of Contrast-Enhanced Ultrasonography to Evaluate the Post-Treatment Responses of Radiofrequency Ablation for Hepatocellular Carcinoma: Comparison with Dynamic CT. ONCOLOGY. 2013. 84. 51-57
Usefulness of Contrast-Enhanced Ultrasonography to Evaluate the Post-Treatment Responses of Radiofrequency Ablation for Hepatocellular Carcinoma: Comparison with Dynamic CT. Oncology. 2013. 84. 51-57
Naoshi Nishida, Tadaaki Arizumi, Masahiro Takita, Satoshi Kitai, Norihisa Yada, Satoru Hagiwara, Tatsuo Inoue, Yasunori Minami, Kazuomi Ueshima, Toshiharu Sakurai, et al. Reactive oxygen species induce epigenetic instability through the formation of 8-hydroxydeoxyguanosine in human hepatocarcinogenesis. Digestive Diseases. 2013. 31. 5-6. 459-466
Naoshi Nishida, Tadaaki Arizumi, Masahiro Takita, Tonnoyuki Nagai, Satoshi Kitai, Norihisa Yada, Satoru Hagiwara, Tatsuo Inoue, Yasunori Minami, Kazuonni Ueshima, et al. Quantification of Tumor DNA in Serum and Vascular Invasion of Human Hepatocellular Carcinoma. ONCOLOGY. 2013. 84. 82-87
上嶋 一臣, 有住 忠晃, 早石 宗右, 田北 雅弘, 北井 聡, 矢田 典久, 井上 達夫, 萩原 智, 南 康範, 櫻井 俊治, et al. 当院における肝細胞癌分子標的治療の現状. 第6回日本肝がん分子標的治療研究会 記録 SORAFENIB PRACTICE BOOK: Sorafenib治療の実践!!多数症例の使用経験を踏まえた治療の実践と問題点の解決を示す. 2012. 25-30
more...
Lectures and oral presentations (57):
TACE不応の進行肝細胞癌に対するソラフェニブ開始時期の検討.
(第9回日本肝がん分子標的治療研究会 2014)
Role of oxidative stress and epigenetic alteration on chronic hepatitis C-related human hepatocarcinogenesis
(The 64th Annual Meeting of the American Association for the Study of Liver Disease (AASLD) 2013)
肝のう胞に対するオレイン酸モノエタノールアミン注入療法の検討
(第17回日本肝臓学会大会(第21回日本消化器関連学会週間JDDW2013) 2013)
C型肝炎に対する3剤併用療法の高齢者における認容性の検討
(第17回日本肝臓学会大会(第21回日本消化器関連学会週間JDDW2013) 2013)
Sorafenib treatment for non-hypervascular hepatocellular carcinoma
(Seventh Annual Conference International Liver Cancer Association (ILCA) 2013)
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM